Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Regimens after ICI therapy and bevacizumab use (N=79)
| Treatment regimens after ICI therapy | n (%) |
|---|---|
| Platinum-based | 37 (47%) |
| Pegylated liposomal doxorubicin (PLD) | 24 (30%) |
| Gemcitabine | 18 (23%) |
| Taxanes | 42 (53%) |
| Topotecan/Irinotecan | 17 (22%) |
| Hormones | 6 (8%) |
| PARP | 10 (13%) |
| Pemetrexed | 15 (19%) |
| Other | 23 (29%) |
|
Bevacizumab after ICI therapy | |
| Yes | 47 (59%) |
| No | 32 (41%) |
ICI, immune checkpoint inhibitor; PARP, poly (ADP-ribose) polymerase
